Market

Closing Bell: Sensex ends mildly higher, Nifty holds 11,050; Sun Pharma top gainer

Updated : August 19, 2019 07:22 PM IST

Indian shares ended mildly higher on Monday, tracking gains in Asian peers, with pharma and IT indices leading the gains.

In broader markets, the Nifty Midcap and the Nifty Smallcap indices advanced 0.26 percent and 0.4 percent, respectively.

Indian shares ended mildly higher on Monday, tracking gains in Asian peers, with pharma and IT indices leading the gains. However, losses in banking and auto stocks capped the gains.

The Sensex ended 52 points higher at 37,402, while the broader Nifty50 index added 6 points to end the day at 11,054.

Asian stocks tracked the Wall Street rally, on signs that major economies would look to prop up stalling growth with fresh stimulus measures, easing pressure on bonds and dampening demand for perceived safe-havens such as gold. MSCI’s broadest index of Asia-Pacific shares outside Japan gained 1.1 percent.

In broader markets, the Nifty Midcap and the Nifty Smallcap indices advanced 0.26 percent and 0.4 percent, respectively.

Sun Pharma, Tech Mahindra, Axis Bank, Bharti Infratel, and Titan were the top gainers on the Nifty50 index, while YES Bank, Grasim, Indiabulls Housing, GAIL, and Coal India led the losses.

Sectoral indices were mixed for the day. The Nifty Pharma index gained the most, up 0.8 percent, followed by the Nifty Media and Nifty Realty, which rose 0.6 percent and 0.4 percent, respectively. Meanwhile, Nifty Auto and the Nifty PSU Bank indices fell 0.35 percent and 0.8 percent, respectively.

Sun Pharma rose 2.7 percent after the company signed a long-term licensing deal to develop generic products in China.

Closing Bell: Sensex ends mildly higher, Nifty holds 11,050; Sun Pharma top gainer

You May Also Like

Tata Power Solar wins Rs 1,200 crore order to set up 320 MW project

Audi Q2: Find out whether it’s an ideal entry-level SUV

UltraTech Cement Q3 net profit jumps 122% to Rs 1,584 crore; Domestic volume growth at 14%

Trending on CNBC-TV18

recommended for you